High affinity C10-O(eq) ester derivatives of ryanodine. Activator- selective agonists of the sarcoplasmic reticulum calcium release channel

R. A. Humerickhouse, K. R. Bidasee, K. Gerzon, J. T. Emmick, S. Kwon, J. L. Sutko, L. Ruest, H. R. Besch

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The plant alkaloids ryanodine and dehydroryanodine are specific and potent modulators of the sarcoplasmic reticulum calcium release channel. In the present study, acidic, basic, and neutral side chains esters of these diterpene compounds were prepared and their pharmacologic activities were assessed. Binding affinities of the novel C10-O(eq) ester derivatives for the sarcoplasmic reticulum Ca2+ release channel were evaluated with sarcoplasmic reticular vesicles prepared from rabbit skeletal muscle. K(d) values of the derivatives varied 500-fold, ranging from 0.5 to 244 nM. In comparison, K(d) values for ryanodine and dehydroryanodine were 4.4 nM and 5.4 nM, respectively. Basic substituents at the C10-O(eq) side chain terminus produced the highest affinity derivatives (K(d) values from 0.5 to 1.3 nM). Neutral and/or hydrophobic side chain derivatives exhibited intermediate affinities for the high affinity ryanodine receptor site (K(d) values from 2.5 to 39 nM), whereas a derivative with a terminal acidic group had the lowest affinity (K(d) value >100 nM). Certain of the higher affinity C10-O(eq) derivatives were evaluated more extensively for their pharmacologic activity on the sarcoplasmic reticular Ca2+ release channel. Both channel activating (opening) and deactivating (closing) actions were assessed from the ability of the ryanoids to alter Ca2+ efflux rates from skeletal junctional sarcoplasmic reticular vesicles that had been passively loaded with Ca2+. The natural Ryania secondary metabolites ryanodine, dehydroryanodine and esters E and F, all exhibit antithetical concentration- effect curves, indicating both activator and deactivator actions. In contrast, the semi-synthetic C10-O(eq) esters selectively activate the Ca2+ release channel. Half-maximal concentrations for such activation (ED(50 (act)) ranged from 0.87 μM to 4.2 μM, compared with an EC(50 act) of 1.3 μM for ryanodine. These derivatives were also evaluated for their ability to augment ATP-dependent Ca2+ accumulation by cardiac junctional sarcoplasmic reticular vesicles, an effect that results from deactivation of the Ca2+ release channels. None of the derivatives tested was able to significantly augment Ca2+ accumulation, further substantiating their inability to deactivate the sarcoplasmic reticular Ca2+ release channel. Additionally, these derivatives functionally antagonized the action of ryanodine to close the Ca2+ release channel. The results presented demonstrate that these C10-O(eq) ester derivatives of ryanodine and dehydroryanodine bind specifically to the SR Ca2+ release channel, selectively activate the channel, and, although they fail to effect channel closure, they nevertheless functionally compete with ryanodine at its low affinity (deactivator) site(s).

Original languageEnglish (US)
Pages (from-to)30243-30253
Number of pages11
JournalJournal of Biological Chemistry
Volume269
Issue number48
StatePublished - Jan 1 1994

Fingerprint

Ryanodine
Sarcoplasmic Reticulum
Calcium Channels
Esters
Calcium
Derivatives
Ryania
Ryanodine Receptor Calcium Release Channel
Diterpenes
Alkaloids
Skeletal Muscle
Adenosine Triphosphate
Metabolites
Rabbits
Modulators
Muscle
Chemical activation

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Humerickhouse, R. A., Bidasee, K. R., Gerzon, K., Emmick, J. T., Kwon, S., Sutko, J. L., ... Besch, H. R. (1994). High affinity C10-O(eq) ester derivatives of ryanodine. Activator- selective agonists of the sarcoplasmic reticulum calcium release channel. Journal of Biological Chemistry, 269(48), 30243-30253.

High affinity C10-O(eq) ester derivatives of ryanodine. Activator- selective agonists of the sarcoplasmic reticulum calcium release channel. / Humerickhouse, R. A.; Bidasee, K. R.; Gerzon, K.; Emmick, J. T.; Kwon, S.; Sutko, J. L.; Ruest, L.; Besch, H. R.

In: Journal of Biological Chemistry, Vol. 269, No. 48, 01.01.1994, p. 30243-30253.

Research output: Contribution to journalArticle

Humerickhouse, RA, Bidasee, KR, Gerzon, K, Emmick, JT, Kwon, S, Sutko, JL, Ruest, L & Besch, HR 1994, 'High affinity C10-O(eq) ester derivatives of ryanodine. Activator- selective agonists of the sarcoplasmic reticulum calcium release channel', Journal of Biological Chemistry, vol. 269, no. 48, pp. 30243-30253.
Humerickhouse, R. A. ; Bidasee, K. R. ; Gerzon, K. ; Emmick, J. T. ; Kwon, S. ; Sutko, J. L. ; Ruest, L. ; Besch, H. R. / High affinity C10-O(eq) ester derivatives of ryanodine. Activator- selective agonists of the sarcoplasmic reticulum calcium release channel. In: Journal of Biological Chemistry. 1994 ; Vol. 269, No. 48. pp. 30243-30253.
@article{f0457976a3594fdfab4e6b0e07007b17,
title = "High affinity C10-O(eq) ester derivatives of ryanodine. Activator- selective agonists of the sarcoplasmic reticulum calcium release channel",
abstract = "The plant alkaloids ryanodine and dehydroryanodine are specific and potent modulators of the sarcoplasmic reticulum calcium release channel. In the present study, acidic, basic, and neutral side chains esters of these diterpene compounds were prepared and their pharmacologic activities were assessed. Binding affinities of the novel C10-O(eq) ester derivatives for the sarcoplasmic reticulum Ca2+ release channel were evaluated with sarcoplasmic reticular vesicles prepared from rabbit skeletal muscle. K(d) values of the derivatives varied 500-fold, ranging from 0.5 to 244 nM. In comparison, K(d) values for ryanodine and dehydroryanodine were 4.4 nM and 5.4 nM, respectively. Basic substituents at the C10-O(eq) side chain terminus produced the highest affinity derivatives (K(d) values from 0.5 to 1.3 nM). Neutral and/or hydrophobic side chain derivatives exhibited intermediate affinities for the high affinity ryanodine receptor site (K(d) values from 2.5 to 39 nM), whereas a derivative with a terminal acidic group had the lowest affinity (K(d) value >100 nM). Certain of the higher affinity C10-O(eq) derivatives were evaluated more extensively for their pharmacologic activity on the sarcoplasmic reticular Ca2+ release channel. Both channel activating (opening) and deactivating (closing) actions were assessed from the ability of the ryanoids to alter Ca2+ efflux rates from skeletal junctional sarcoplasmic reticular vesicles that had been passively loaded with Ca2+. The natural Ryania secondary metabolites ryanodine, dehydroryanodine and esters E and F, all exhibit antithetical concentration- effect curves, indicating both activator and deactivator actions. In contrast, the semi-synthetic C10-O(eq) esters selectively activate the Ca2+ release channel. Half-maximal concentrations for such activation (ED(50 (act)) ranged from 0.87 μM to 4.2 μM, compared with an EC(50 act) of 1.3 μM for ryanodine. These derivatives were also evaluated for their ability to augment ATP-dependent Ca2+ accumulation by cardiac junctional sarcoplasmic reticular vesicles, an effect that results from deactivation of the Ca2+ release channels. None of the derivatives tested was able to significantly augment Ca2+ accumulation, further substantiating their inability to deactivate the sarcoplasmic reticular Ca2+ release channel. Additionally, these derivatives functionally antagonized the action of ryanodine to close the Ca2+ release channel. The results presented demonstrate that these C10-O(eq) ester derivatives of ryanodine and dehydroryanodine bind specifically to the SR Ca2+ release channel, selectively activate the channel, and, although they fail to effect channel closure, they nevertheless functionally compete with ryanodine at its low affinity (deactivator) site(s).",
author = "Humerickhouse, {R. A.} and Bidasee, {K. R.} and K. Gerzon and Emmick, {J. T.} and S. Kwon and Sutko, {J. L.} and L. Ruest and Besch, {H. R.}",
year = "1994",
month = "1",
day = "1",
language = "English (US)",
volume = "269",
pages = "30243--30253",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "48",

}

TY - JOUR

T1 - High affinity C10-O(eq) ester derivatives of ryanodine. Activator- selective agonists of the sarcoplasmic reticulum calcium release channel

AU - Humerickhouse, R. A.

AU - Bidasee, K. R.

AU - Gerzon, K.

AU - Emmick, J. T.

AU - Kwon, S.

AU - Sutko, J. L.

AU - Ruest, L.

AU - Besch, H. R.

PY - 1994/1/1

Y1 - 1994/1/1

N2 - The plant alkaloids ryanodine and dehydroryanodine are specific and potent modulators of the sarcoplasmic reticulum calcium release channel. In the present study, acidic, basic, and neutral side chains esters of these diterpene compounds were prepared and their pharmacologic activities were assessed. Binding affinities of the novel C10-O(eq) ester derivatives for the sarcoplasmic reticulum Ca2+ release channel were evaluated with sarcoplasmic reticular vesicles prepared from rabbit skeletal muscle. K(d) values of the derivatives varied 500-fold, ranging from 0.5 to 244 nM. In comparison, K(d) values for ryanodine and dehydroryanodine were 4.4 nM and 5.4 nM, respectively. Basic substituents at the C10-O(eq) side chain terminus produced the highest affinity derivatives (K(d) values from 0.5 to 1.3 nM). Neutral and/or hydrophobic side chain derivatives exhibited intermediate affinities for the high affinity ryanodine receptor site (K(d) values from 2.5 to 39 nM), whereas a derivative with a terminal acidic group had the lowest affinity (K(d) value >100 nM). Certain of the higher affinity C10-O(eq) derivatives were evaluated more extensively for their pharmacologic activity on the sarcoplasmic reticular Ca2+ release channel. Both channel activating (opening) and deactivating (closing) actions were assessed from the ability of the ryanoids to alter Ca2+ efflux rates from skeletal junctional sarcoplasmic reticular vesicles that had been passively loaded with Ca2+. The natural Ryania secondary metabolites ryanodine, dehydroryanodine and esters E and F, all exhibit antithetical concentration- effect curves, indicating both activator and deactivator actions. In contrast, the semi-synthetic C10-O(eq) esters selectively activate the Ca2+ release channel. Half-maximal concentrations for such activation (ED(50 (act)) ranged from 0.87 μM to 4.2 μM, compared with an EC(50 act) of 1.3 μM for ryanodine. These derivatives were also evaluated for their ability to augment ATP-dependent Ca2+ accumulation by cardiac junctional sarcoplasmic reticular vesicles, an effect that results from deactivation of the Ca2+ release channels. None of the derivatives tested was able to significantly augment Ca2+ accumulation, further substantiating their inability to deactivate the sarcoplasmic reticular Ca2+ release channel. Additionally, these derivatives functionally antagonized the action of ryanodine to close the Ca2+ release channel. The results presented demonstrate that these C10-O(eq) ester derivatives of ryanodine and dehydroryanodine bind specifically to the SR Ca2+ release channel, selectively activate the channel, and, although they fail to effect channel closure, they nevertheless functionally compete with ryanodine at its low affinity (deactivator) site(s).

AB - The plant alkaloids ryanodine and dehydroryanodine are specific and potent modulators of the sarcoplasmic reticulum calcium release channel. In the present study, acidic, basic, and neutral side chains esters of these diterpene compounds were prepared and their pharmacologic activities were assessed. Binding affinities of the novel C10-O(eq) ester derivatives for the sarcoplasmic reticulum Ca2+ release channel were evaluated with sarcoplasmic reticular vesicles prepared from rabbit skeletal muscle. K(d) values of the derivatives varied 500-fold, ranging from 0.5 to 244 nM. In comparison, K(d) values for ryanodine and dehydroryanodine were 4.4 nM and 5.4 nM, respectively. Basic substituents at the C10-O(eq) side chain terminus produced the highest affinity derivatives (K(d) values from 0.5 to 1.3 nM). Neutral and/or hydrophobic side chain derivatives exhibited intermediate affinities for the high affinity ryanodine receptor site (K(d) values from 2.5 to 39 nM), whereas a derivative with a terminal acidic group had the lowest affinity (K(d) value >100 nM). Certain of the higher affinity C10-O(eq) derivatives were evaluated more extensively for their pharmacologic activity on the sarcoplasmic reticular Ca2+ release channel. Both channel activating (opening) and deactivating (closing) actions were assessed from the ability of the ryanoids to alter Ca2+ efflux rates from skeletal junctional sarcoplasmic reticular vesicles that had been passively loaded with Ca2+. The natural Ryania secondary metabolites ryanodine, dehydroryanodine and esters E and F, all exhibit antithetical concentration- effect curves, indicating both activator and deactivator actions. In contrast, the semi-synthetic C10-O(eq) esters selectively activate the Ca2+ release channel. Half-maximal concentrations for such activation (ED(50 (act)) ranged from 0.87 μM to 4.2 μM, compared with an EC(50 act) of 1.3 μM for ryanodine. These derivatives were also evaluated for their ability to augment ATP-dependent Ca2+ accumulation by cardiac junctional sarcoplasmic reticular vesicles, an effect that results from deactivation of the Ca2+ release channels. None of the derivatives tested was able to significantly augment Ca2+ accumulation, further substantiating their inability to deactivate the sarcoplasmic reticular Ca2+ release channel. Additionally, these derivatives functionally antagonized the action of ryanodine to close the Ca2+ release channel. The results presented demonstrate that these C10-O(eq) ester derivatives of ryanodine and dehydroryanodine bind specifically to the SR Ca2+ release channel, selectively activate the channel, and, although they fail to effect channel closure, they nevertheless functionally compete with ryanodine at its low affinity (deactivator) site(s).

UR - http://www.scopus.com/inward/record.url?scp=0028171898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028171898&partnerID=8YFLogxK

M3 - Article

C2 - 7982934

AN - SCOPUS:0028171898

VL - 269

SP - 30243

EP - 30253

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 48

ER -